Skip to main content

Published locations for Panel backs approval of alirocumab, biologic injectable lipid-lowering drug

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Panel backs approval of alirocumab, biologic injectable lipid-lowering drug

User login

  • Reset your password
  • /content/panel-backs-approval-alirocumab-biologic-injectable-lipid-lowering-drug
  • /familypracticenews/article/100334/cad-atherosclerosis/panel-backs-approval-alirocumab-biologic
  • /internalmedicinenews/article/100334/cad-atherosclerosis/panel-backs-approval-alirocumab-biologic
  • /clinicalendocrinologynews/article/100334/cad-atherosclerosis/panel-backs-approval-alirocumab
  • /diabeteshub/article/100334/cad-atherosclerosis/panel-backs-approval-alirocumab-biologic-injectable
  • /ecardiologynews/article/100334/cad-atherosclerosis/panel-backs-approval-alirocumab-biologic
  • /cardiology/article/100334/cad-atherosclerosis/panel-backs-approval-alirocumab-biologic-injectable
  • /endocrinology/article/100334/cad-atherosclerosis/panel-backs-approval-alirocumab-biologic-injectable
  • /internalmedicine/article/100334/cad-atherosclerosis/panel-backs-approval-alirocumab-biologic
  • /familymedicine/article/100334/cad-atherosclerosis/panel-backs-approval-alirocumab-biologic